[HTML][HTML] Targeting adenosine receptor signaling in cancer immunotherapy

K Sek, C Mølck, GD Stewart, L Kats, PK Darcy… - International journal of …, 2018 - mdpi.com
The immune system plays a major role in the surveillance and control of malignant cells,
with the presence of tumor infiltrating lymphocytes (TILs) correlating with better patient …

[HTML][HTML] Pancreatic ductal adenocarcinoma: a strong imbalance of good and bad immunological cops in the tumor microenvironment

ED Foucher, C Ghigo, S Chouaib, J Galon… - Frontiers in …, 2018 - frontiersin.org
Pancreatic ductal adenocarcinoma (PDAC) is one of the most aggressive and lethal cancers
with very few available treatments. For many decades, gemcitabine was the only treatment …

[HTML][HTML] The pro-tumorigenic IL-33 involved in antitumor immunity: a yin and yang cytokine

JJ Fournié, M Poupot - Frontiers in immunology, 2018 - frontiersin.org
Interleukin-33 (IL-33), considered as an alarmin released upon tissue stress or damage, is a
member of the IL-1 family and binds the ST2 receptor. First described as a potent initiator of …

T cells and their immunometabolism: A novel way to understanding sepsis immunopathogenesis and future therapeutics

V Kumar - European journal of cell biology, 2018 - Elsevier
Sepsis has always been considered as a big challenge for pharmaceutical companies in
terms of discovering and designing new therapeutics. The pathogenesis of sepsis involves …

[HTML][HTML] Th17 response in patients with cervical cancer

JJP Alves, TAADM Fernandes… - Oncology …, 2018 - spandidos-publications.com
Persistent infection by high‑risk human papillomavirus (HR‑HPV) is the main risk factor for
uterine cervical cancer (UCC). However, viral infection alone is not sufficient for the …

[PDF][PDF] JAK/STAT5 signaling pathway inhibitor ruxolitinib reduces airway inflammation of neutrophilic asthma in mice model.

RF Li, GF Wang - European Review for Medical & …, 2018 - europeanreview.org
OBJECTIVE: The aim of this study was to explore the role of JAK/STAT signaling pathway
inhibitor Ruxolitinib in neutrophilic airway inflammation and its possible immunological …

[PDF][PDF] JÚLIO DE MESQUITA FILHO

AB ORLANDO - repositorio.unesp.br
A resolução de reações inflamatórias é caracterizada pela fagocitose de células mortas,
processo denominado eferocitose. Como consequência deste processo, há a produção dos …

[PDF][PDF] BBA-Reviews on Cancer

T Li, B Wu, T Yang, L Zhang, K Jin - researchgate.net
Over the past decades, tumor-resident immune cells have been extensively studied to
dissect their biological functions and clinical roles. Tumor-infiltrating CD8+ T cells, because …

Mecanismo pelo qual Prostaglandina E2 oriunda da eferocitose inibe a expressão do IL-1R ea diferenciação de Th17

AB Orlando - 2018 - repositorio.unesp.br
A resolução de reações inflamatórias é caracterizada pela fagocitose de células mortas,
processo denominado eferocitose. Como consequência deste processo, há a produção dos …

[HTML][HTML] Perfil de expresión génica

Y Bestach, M Ferrulli, A Krzywinski… - … : Volumen 22-Nº2, 2018 - books.google.com
Imatinib representa la terapia de primera línea actual para pacientes con leucemia mieloide
crónica (LMC). Además de su acción directa inhibiendo BCR-ABL1, también podría modular …